Cover Image
市場調查報告書

藥物安全檢測及醫藥品安全確保軟體的全球市場 2019年:AER軟體·完全整合型軟體

Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs): Global Forecast to 2019

出版商 MarketsandMarkets 商品編碼 328009
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
藥物安全檢測及醫藥品安全確保軟體的全球市場 2019年:AER軟體·完全整合型軟體 Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs): Global Forecast to 2019
出版日期: 2015年03月26日 內容資訊: 英文 136 Pages
簡介

全球藥物安全檢測軟體市場預測從2014年到2019年將以6.5%的年複合成長率成長,到2019年達到1億5410萬美元的規模。全球醫藥品安全確保的軟體市場受到藥物有害反應 (ADR:Adverse Drug Reaction) 的發病率上升和外部委託業者的藥物安全檢測軟體擴大引進等要素推動,而促進了成長。

本報告提供全球藥物安全檢測及醫藥品安全確保軟體的市場相關調查,提供您產業概要與價值鏈,藥物安全檢測及醫藥品安全確保的軟體種類與概要,功能性·傳送模式·各終端用戶的市場趨勢及市場成長預測,地區及各主要國家趨勢,市場成長的主要影響因素及市場機會分析,競爭環境與市場佔有率,並彙整主要企業的簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 產業分析

  • 簡介
  • 價值鏈分析
  • 波特的五力分析

第7章 藥物安全檢測及醫藥品安全確保軟體的市場:各功能

  • 簡介
  • AER (不利事件報告) 軟體
  • 醫藥品安全性審核軟體
  • 問題追蹤軟體
  • 完全整合型軟體

第8章 藥物安全檢測及醫藥品的安全確保軟體市場:傳送模式別

  • 簡介
  • 內部部署
  • 隨選/雲端

第9章 藥物安全檢測及醫藥品的安全確保軟體市場:各終端用戶

  • 簡介
  • 醫藥品·生物科技企業
  • CRO
  • BPO
  • 其他藥物安全檢測服務供應商

第10章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他
    • 南美
    • 中東
    • 非洲

第11章 競爭環境

  • 概要
  • 主要企業的市場佔有率分析
  • 競爭情形·趨勢
  • 近幾年的發展趨勢
    • M&A
    • 協定·聯盟·合作·合資企業
    • 新產品的投入
    • 擴張
    • 其他

第12章 企業簡介

  • AB-Cube
  • Arisglobal
  • Extedo GMBH.
  • Ennov.
  • Online Business Applications, Inc
  • Oracle Corporation.
  • Sarjen Systems Pvt. Ltd
  • Sparta Systems, Inc
  • United Biosource Corporation
  • Umbra Global
    • 財務狀況
    • 產品與服務
    • 主要策略
    • 近幾年的發展趨勢等

第13章 附錄

目錄
Product Code: HIT 3268

The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.

The growth of the global pharmacovigilance and drug safety software market is mainly driven by increasing incidence rates of adverse drug reactions (ADRs), growing adoption of pharmacovigilance software by outsourcing companies (such as CROs and BPOs), and huge pressure on pharma companies to develop novel and safe drugs. However, the dearth of standard regulations and lack of pharmacovigilance professionals are some of the key factors restraining the growth of this market.

In this report, the global pharmacovigilance and drug safety software market has been classified into four segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is segmented into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

The global pharmacovigilance and drug safety software market comprises large number of small and mid-size software developers and service providers. As of 2014, the global pharmacovigilance and drug safety software market was dominated by Oracle Corporation (U.S.).

New service launches; agreements, and partnerships; software developments; and geographical expansions are some of the major strategies adopted by most of the market players to achieve growth in the pharmacovigilance and drug safety software market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis -industry analysis (value chain analysis and Porter's five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the pharmacovigilance and drug safety software market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned four strategies (market penetration, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on pharmacovigilance and drug safety software offered by the top 10 players in the pharmacovigilance and drug safety software market. The report analyzes the pharmacovigilance and drug safety software market on the basis of functionality, delivery mode, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pharmacovigilance and drug safety software across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmacovigilance and drug safety software market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the pharmacovigilance and drug safety software market.

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Market Segmentation
    • 1.3.2. Years Considered for the Study
  • 1.4. Limitation
  • 1.5. Market Stakeholders

2. Research Methodology

  • 2.1. Research Data
    • 2.1.1. Secondary Data
      • 2.1.1.1. Key Data From Secondary Sources
    • 2.1.2. Primary Data
      • 2.1.2.1. Key Data From Primary Sources
      • 2.1.2.2. Key Industry Insights
      • 2.1.2.3. Breakdown of Primaries
  • 2.2. Market Size Estimation
    • 2.2.1.1. Bottom-Up Approach
    • 2.2.1.2. Top-Down Approach
  • 2.3. Market Breakdown and Data Triangulation
  • 2.4. Research Assumptions

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Current Scenario
  • 3.3. Future Outlook
  • 3.4. Conclusion

4. Premium Insights

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunities
    • 5.3.4. Challenges

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Value Chain Analysis
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Threat From New Entrants
    • 6.3.2. Threat From Substitutes
    • 6.3.3. Bargaining Power of Suppliers
    • 6.3.4. Bargaining Power of Buyers
    • 6.3.5. Intensity of Competitive Rivalry

7. Pharmacovigilance and Drug Safety Software Market, By Functionality

  • 7.1. Introduction
  • 7.2. Adverse Event Reporting Software
  • 7.3. Drug Safety Audits Software
  • 7.4. Issue Tracking Software
  • 7.5. Fully Integrated Software

8. Pharmacovigilance and Drug Safety Software Market, By Delivery Mode

  • 8.1. Introduction
  • 8.2. On-Premise Delivery Mode
  • 8.3. On-Demand/Cloud Based (Saas) Delivery Mode

9. Pharmacovigilance and Drug Safety Software Market, By End-Users

  • 9.1. Introduction
  • 9.2. Pharma and Biotech Companies
  • 9.3. Contract Research Organizations (CROS)
  • 9.4. Business Process Outsourcing (BPO) Firms
  • 9.5. Other Pharmacovigilance Service Providers

10. Geographic Analysis

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.1. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.1. U.K.
    • 10.3.1. France.
    • 10.3.1. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.1. China
    • 10.4.1. India
    • 10.4.1. Rest of Asia-Pacific
  • 10.5. ROW (Rest of the World)
    • 10.5.1. Latin America
    • 10.5.1. Middle East
    • 10.5.1. Africa

11. Competitive Landscape

  • 11.1. Overview
  • 11.2. Market Share Analysis, By Key Players, 2014
  • 11.3. Competitive Situation and Trends
  • 11.4. Recent Developments
    • 11.4.1. Mergers & Acquisitions
    • 11.4.2. Agreements, Partnerships, Collaborations & Joint Ventures
    • 11.4.3. New Product Launches
    • 11.4.4. Expansions
    • 11.4.5. Other Developments

12. Company Profile

  • 12.1. AB-Cube
  • 12.2. Arisglobal
  • 12.3. Extedo GMBH.
  • 12.4. Ennov.
  • 12.5. Online Business Applications, Inc
  • 12.6. Oracle Corporation.
  • 12.7. Sarjen Systems Pvt. Ltd
  • 12.8. Sparta Systems, Inc
  • 12.9. United Biosource Corporation
  • 12.1. Umbra Global

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13. Appendix

List of Tables

  • Table 1: Global Pharmacovigilance Software Market Size, By Functionality, 2012-2019 ($Million)
  • Table 2: Global Adverse Event Reporting Pharmacovigilance Software Market Size, By Region, 2012-2019 ($Million)
  • Table 3: Global Drug Safety Audits Pharmacovigilance Software Market Size, By Region, 2012-2019 ($Million)
  • Table 4: Global Issue Tracking Pharmacovigilance Software Market Size, By Region, 2012-2019 ($Million)
  • Table 5: Global Fully Integrated Pharmacovigilance Software Market Size, By Region, 2012-2019 ($Million)
  • Table 6: Global Drug Safety Software Market Size, By Delivery Mode, 2012-2019 ($Million)
  • Table 7: Global On-Premise Based Pharmacovigilance Software Market Size, By Region, 2012-2019 ($Million)
  • Table 8: Global On-Demand/Cloud Based Drug Safety Software Market Size, By Region, 2012-2019 ($Million)
  • Table 9: Global Pharmacovigilance Software Market Size, By End User, 2012-2019 ($Million)
  • Table 10: Global Pharmacovigilance Software Market Size for Pharma and Biotech Companies, By Region, 2012-2019 ($Million)
  • Table 11: Global Pharmacovigilance Software Market Size for Contract Research Organizations (CROS), By Region, 2012-2019 ($Million)
  • Table 12: Global Drug Safety Software Market Size for Business Process Outsourcing (BPO) Firms, By Region, 2012-2019 ($Million)
  • Table 13: Global Pharmacovigilance Software Market Size for Other Pharmacovigilance Service Providers, By Region, 2012-2019 ($Million)
  • Table 14: Global Pharmacovigilance Software Market Size, By Region, 2012-2019 ($Million)
  • Table 15: North American Pharmacovigilance Software Market, By Country (2014-2019)
  • Table 16: North American Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 17: North American Drug Safety Software Market, By Delivery Mode (2014-2019)
  • Table 18: North American Pharmacovigilance Software Market, By End User (2014-2019)
  • Table 19: U.S. Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 20: U.S. Drug Safety Software Market, By Delivery Mode (2014-2019)
  • Table 21: U.S. Pharmacovigilance Software Market, By End User (2014-2019)
  • Table 22: Canada Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 23: Canada Pharmacovigilance Software Market, By Delivery Mode (2014-2019)
  • Table 24: Canada Drug Safety Software Market, By End User (2014-2019)
  • Table 25: European Pharmacovigilance Software Market, By Country (2014-2019)
  • Table 26: European Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 27: European Market, By Delivery Mode (2014-2019)
  • Table 28: European Pharmacovigilance Software Market, By End User (2014-2019)
  • Table 29: Germany Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 30: Germany Market, By Delivery Mode (2014-2019)
  • Table 31: Germany Drug Safety Software Market, By End User (2014-2019)
  • Table 32: U.K. Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 33: U.K. Market, By Delivery Mode (2014-2019)
  • Table 34: U.K. Pharmacovigilance Software Market, By End User (2014-2019)
  • Table 35: France Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 36: France Drug Safety Software Market, By Delivery Mode (2014-2019)
  • Table 37: France Market, By End User (2014-2019)
  • Table 38: Rest of Europe Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 39: Rest of Europe Pharmacovigilance Software Market, By Delivery Mode (2014-2019)
  • Table 40: Rest of Europe Market, By End User (2014-2019)
  • Table 41: Asia-Pacific Pharmacovigilance Software Market, By Country (2014-2019)
  • Table 42: Asia-Pacific Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 43: Asia-Pacific Pharmacovigilance Software Market, By Delivery Mode (2014-2019)
  • Table 44: Asia-Pacific Drug Safety Software Market, By End User (2014-2019)
  • Table 45: Japan Market, By Functionality (2014-2019)
  • Table 46: Japan Pharmacovigilance Software Market, By Delivery Mode (2014-2019)
  • Table 47: Japan Drug Safety Software Market, By End User (2014-2019)
  • Table 48: China Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 49: China Market, By Delivery Mode (2014-2019)
  • Table 50: China Drug Safety Software Market, By End User (2014-2019)
  • Table 51: India Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 52: India Drug Safety Software Market, By Delivery Mode (2014-2019)
  • Table 53: India Market, By End User (2014-2019)
  • Table 54: Rest of Asia-Pacific Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 55: Rest of Asia-Pacific Market, By Delivery Mode (2014-2019)
  • Table 56: Rest of Asia-Pacific Drug Safety Software Market, By End User (2014-2019)
  • Table 57: ROW Pharmacovigilance Software Market, By Country (2014-2019)
  • Table 58: ROW Drug Safety Software Market, By Functionality (2014-2019)
  • Table 59: ROW Market, By Delivery Mode (2014-2019)
  • Table 60: ROW Drug Safety Software Market, By End User (2014-2019)
  • Table 61: Latin America Drug Safety Software Market, By Functionality (2014-2019)
  • Table 62: Latin America Market, By Delivery Mode (2014-2019)
  • Table 63: Latin America Pharmacovigilance Market, By End User (2014-2019)
  • Table 64: Middle East Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 65: Middle East Market, By Delivery Mode (2014-2019)
  • Table 66: Middle Drug Safety Software East Market, By End User (2014-2019)
  • Table 67: Africa Pharmacovigilance Software Market, By Functionality (2014-2019)
  • Table 68: Africa Pharmacovigilance Software Market, By Delivery Mode (2014-2019)
  • Table 69: Africa Pharmacovigilance Software Market, By End User (2014-2019)
  • Table 70: Top 5 Agreements, Partnerships, and Alliances, 2012-2014
  • Table 71: Top 5 New Services Launches, 2012-2014
  • Table 72: New Product Catalog Launches and Product Enhancements, 2012-2014
  • Table 73: Top 5 New Facility Launches and Expansions, 2012-2014
  • Table 74: Top 5 Other Developments, 2012-2014

List of Figures

  • Figure 1: Global Pharmacovigilance Software Market, By Functionality
  • Figure 2: Global Pharmacovigilance Software Market, By Delivery Mode
  • Figure 3: Global Drug Safety Software Market, By End User
  • Figure 4: Pharmacovigilance Software Market, By Region
  • Figure 5: Research Design
  • Figure 6: Incidence of Cancer, By Region, 2008 vs. 2012
  • Figure 7: Number of New Cancer Cases, By Country (2012 vs. 2020)
  • Figure 8: Prevalence of Cancer for the Next 3 and 5 Years, By Country
  • Figure 9: Burden of Cardiovascular Disease, By Region - From 2005 to 2030
  • Figure 10: Public Healthcare Expenditure (% of Total Healthcare Expenditure) in Developed Markets - 2010 to 2012
  • Figure 11: Bottom-Up Approach
  • Figure 12: Top-Down Approach
  • Figure 13: Assumptions of the Research Study
  • Figure 14: Limitations of the Research Study
  • Figure 15: Global Pharmacovigilance Software Market, By Functionality, 2014
  • Figure 16: Global Market for Functionality, By Region, 2014 vs. 2019
  • Figure 17: Adverse Event Reporting Software Segment is Expected to Double in the Forecast Period
  • Figure 18: Drug Safety Audits Software Segment is Growing at A High CAGR in the North America
  • Figure 19: North America Region Commands the Largest Share of the Global Drug Safety Software Market, 2014
  • Figure 20: Asia-Pacific Region is the Fastest Growing Market in the Global Pharmacovigilance Software Market, 2014
  • Figure 21: More Than 60% of the Market Share is Covered By the Adverse Event Reporting Software Segment, 2014
  • Figure 22: North American Pharmacovigilance Software Market Size is Expected to Double By 2019
  • Figure 23: Increasing Privatization of the Healthcare Sector is Propelling the Market Growth
  • Figure 24: Adverse Event Reporting Software to Drive the Market Growth in North America
  • Figure 25: Fully Integrated Drug Safety Software Market is Expected to Double in the Next Five Years
  • Figure 26: Adverse Event Reporting and Fully Integrated Pharmacovigilance Software Market Are Driving the Market Growth
  • Figure 27: The Top Two Product Segments Will Account for More Than 80% of the Total Market By 2019
  • Figure 28: North America Accounts for the Largest Share of the Global Drug Safety Software Market in 2014
  • Figure 29: Fully Integrated Software to Grow at the Fastest Rate in During the Forecast Period
  • Figure 30: North America Dominates the Global Drug Safety Software Market
  • Figure 31: Global Market, By Delivery Mode
  • Figure 32: Global Market, By Region
  • Figure 33: On-Premise Delivery Mode is Having More Than 60% Market Share in the Global Pharmacovigilance Software Market
  • Figure 34: On-Demand/Cloud Based Delivery Mode is the Fastest Growing Segment in the Global Market
  • Figure 35: Huge Demand for Pharmacovigilance Software in Emerging Markets: A New Growing Opportunity for Market Players
  • Figure 36: Complex Regulations in Certain Countries for Drug Safety is A Key Challenge Market
  • Figure 37: Value Chain Analysis (2014)
  • Figure 38: Porter's Five Forces Analysis
  • Figure 39: Global Pharmacovigilance Software Market, By End User
  • Figure 40: Contract Research Organizations (CROS) Segment Held the Lagest Market Share in the Global Market, By End User
  • Figure 41: Business Process Outsourcing (BPO) Firms Segment is the Fastest Growing Market in the Global Market, By End User
  • Figure 42: On-Premise Segment is Driving the Growth of the Global Pharmacovigilance Software Market
  • Figure 43: North America Commanded Largest Share of the Market in 2014
  • Figure 44: North America Will Continue to Dominate the Adverse Event Reporting Market in the Next Five Years
  • Figure 46: Asia-Pacific to Grow at the Highest CAGR in the Market in the Next Five Years
  • Figure 47: North America Commanded Lion's Share of the Fully Integrated Market in 2014
  • Figure 48: Asia-Pacific to Grow at the Highest CAGR in the On-Demand/Cloud Based Pharmacovigilance Software Market in the Forecast Period
  • Figure 49: North America Will Drive the Growth of the Drug Safety Software Market for Contract Research Organizations (CROS) in the Forecast Period
  • Figure 50: Asia-Pacific to Grow at the Highest CAGR in the Pharmacovigilance Market for Business Process Outsourcing (BPO) Firms in the Next Five Years
  • Figure 51: North America Market Snapshot: Demand Will Be Driven By Presence of Large Number Contract Research Organizations (CROS)
  • Figure 52: Europe Market Snapshot: Increasing Private Healthcare Sector in Central and Eastern Europe Are Key Factors to Drive the Market Growth
  • Figure 53: Asia-Pacific Market Snapshot: High Demand for Pharmacovigilance By Low-Budget Pharma and Biotech Companies Will Continue Drive the Market Growth
  • Figure 54: Leading Market Players Adopted Agreements, Partnerships, and Alliances as Key Growth Strategies During 2012-2014
  • Figure 55: Global Drug Safety Software Market Share, By Key Player, 2014
  • Figure 56: Agreements, Partnerships, and Alliances Are the Key Strategies
  • Figure 57: Oracle Corporation Company: Company Snapshot
Back to Top